Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy

scientific article published on 28 August 2016

Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JURO.2016.08.097
P932PMC publication ID5241234
P698PubMed publication ID27582434

P50authorBradford J. WoodQ40114938
Michael KongnyuyQ88591511
Baris TurkbeyQ88769455
Peter L ChoykeQ90059714
Peter A PintoQ90059716
Arvin K GeorgeQ96240193
Maria J MerinoQ107749611
Akhil MuthigiQ114423767
Abhinav SidanaQ114423774
P2093author name stringRichard Simon
Vanessa Moreno
P2860cites workClinical application of a 3D ultrasound-guided prostate biopsy systemQ24608010
Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.Q30664726
Multiparametric MRI in the PSA screening eraQ34177428
Gleason 6 Prostate Cancer: Translating Biology into Population HealthQ34470640
Documenting the location of prostate biopsies with image fusionQ35738511
Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy.Q36386904
Real-time MRI-TRUS fusion for guidance of targeted prostate biopsiesQ37149144
Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic ReviewQ38278155
Optimizing Patient Population for MP-MRI and Fusion Biopsy for Prostate Cancer DetectionQ38524498
Navigating MRI-TRUS fusion biopsy: optimizing the process and avoiding technical pitfalls.Q38664945
Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results.Q38708189
Prostate cancer risk stratification with magnetic resonance imagingQ38796980
A urologist's perspective on prostate cancer imaging: past, present, and futureQ38823661
Prostate Cancer Diagnosis on Repeat Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy of Benign Lesions: Recommendations for Repeat SamplingQ39994543
Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidanceQ40211606
In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?Q40224363
Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostateQ40508438
Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failureQ40524688
Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidanceQ40832222
Posterior subcapsular prostate cancer: identification with mpMRI and MRI/TRUS fusion-guided biopsyQ41217708
Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy StrategiesQ42237453
Reproducibility of Multiparametric Magnetic Resonance Imaging and Fusion Guided Prostate Biopsy: Multi-Institutional External Validation by a Propensity Score Matched CohortQ47905143
Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?Q48006856
Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla.Q50244812
Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions.Q53111203
Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy.Q53304507
The Role of Image Guided Biopsy Targeting in Patients with Atypical Small Acinar ProliferationQ57305669
Comparison of magnetic resonance imaging and ultrasound (MRI-US) fusion-guided prostate biopsies obtained from axial and sagittal approachesQ57317475
Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implicationsQ71870897
Heterogeneity of prostate cancer in radical prostatectomy specimensQ72716230
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectprostate cancerQ181257
biopsyQ179991
P304page(s)327-334
P577publication date2016-08-28
P1433published inJournal of UrologyQ15709979
P1476titleMissing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy
P478volume197

Reverse relations

cites work (P2860)
Q33890165A critical comparison of techniques for MRI-targeted biopsy of the prostate
Q57824787A magnetic resonance imaging-based prediction model for prostate biopsy risk stratification
Q47097032A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic transperineal biopsy with the average of 18-cores to detect clinically significant prostate cancer.
Q45874542Acquired Hemophilia presenting as Gross Hematuria following Kidney Stone - A Case Report and Review of the Literature
Q47842160Defining Novel and Practical Metrics to Assess the Deliverables of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy
Q38718163Detection of prostate cancer in multiparametric MRI using random forest with instance weighting
Q50112903Future Perspectives and Challenges of Prostate MR Imaging
Q90466016Lowering positive margin rates at radical prostatectomy by color coding of biopsy specimens to permit individualized preservation of the neurovascular bundles: is it feasible? a pilot investigation
Q47949163Magnetic resonance imaging in the early detection of prostate cancer and review of the literature on magnetic resonance imaging-stratified clinical pathways
Q97652914Mosquito proboscis-inspired needle insertion to reduce tissue deformation and organ displacement
Q38641232Multimodality Image Fusion with PSMA PET/CT and High-Intensity Focused Ultrasound Focal Therapy for Primary Diagnosis and Management of Prostate Cancer: A Planned Research Initiative
Q91969165Multiparametric MRI for prostate cancer diagnosis: current status and future directions
Q38691219Multiparametric MRI/ultrasound fusion-guided biopsy decreases detection of indolent cancer in African-American men.
Q42374568Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer
Q39446378Multiparametric magnetic resonance imaging of the prostate-a basic tutorial
Q90342447Needle deflection and tissue sampling length in needle biopsy
Q39108592PRECISION MANAGEMENT OF LOCALIZED PROSTATE CANCER.
Q53300364Postoperative upgrading of prostate cancer in men ≥75 years: a propensity score-matched analysis.
Q89125002Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions
Q50075913Prostate cancer recurrence in vas deferens - fusion image guide as an important tool in dignosis
Q58562204Prostate imaging features that indicate benign or malignant pathology on biopsy
Q64083296Spatial distribution of biopsy cores and the detection of intra-lesion pathologic heterogeneity
Q57109743Targets missed: predictors of MRI-targeted biopsy failing to accurately localize prostate cancer found on systematic biopsy
Q104504831The utility of in-bore multiparametric magnetic resonance-guided biopsy in men with negative multiparametric magnetic resonance-ultrasound software-based fusion targeted biopsy
Q88769459Validation of PI-RADS Version 2 in Transition Zone Lesions for the Detection of Prostate Cancer

Search more.